Literature DB >> 27262042

Selection of cognitive tests for trials of therapeutic agents.

John E Harrison1, Raymond W Lam2, Bernhard T Baune3, Roger S McIntyre4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27262042     DOI： 10.1016/S2215-0366(16)30067-0

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  4 in total

Review 1.  A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples.

Authors:  Catherine E Prado; Stephanie Watt; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2018-02-14       Impact factor: 7.444

2.  The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change.

Authors:  Roger S McIntyre; Mehala Subramaniapillai; Caroline Park; Hannah Zuckerman; Bing Cao; Yena Lee; Michelle Iacobucci; Flora Nasri; Dominika Fus; Christopher R Bowie; Tanya Tran; Joshua D Rosenblat; Rodrigo B Mansur
Journal:  Front Psychiatry       Date:  2020-06-24       Impact factor: 4.157

3.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 4.  FDA position statement "Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry".

Authors:  Marwan N Sabbagh; Suzanne Hendrix; John E Harrison
Journal:  Alzheimers Dement (N Y)       Date:  2019-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.